- Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
Clinical trials
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) -
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection - Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 85 Years
- Sexes
- All
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) - Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
-
Real-time and long-term effects of medical marijuana on older adults with chronic pain; A prospective cohort study - Ages
- 50 Years - N/A
- Sexes
- All
-
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial - Investigator
- Mehdi S Mirsaeidi
- Ages
- 30 Years - NA Years
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 75 Years
- Sexes
- All